DOCSLIB.ORG

High Expression of the Chemokine Receptor CCR3 in Human Blood Basophils

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
High Expression of the Chemokine Receptor CCR3 in Human Blood Basophils High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. M Uguccioni, … , M Baggiolini, C A Dahinden J Clin Invest. 1997;100(5):1137-1143. https://doi.org/10.1172/JCI119624. Research Article Eosinophil leukocytes express high numbers of the chemokine receptor CCR3 which binds eotaxin, monocyte chemotactic protein (MCP)-4, and some other CC chemokines. In this paper we show that CCR3 is also highly expressed on human blood basophils, as indicated by Northern blotting and flow cytometry, and mediates mainly chemotaxis. Eotaxin and MCP-4 elicited basophil migration in vitro with similar efficacy as regulated upon activation normal T cells expressed and secreted (RANTES) and MCP-3. They also induced the release of histamine and leukotrienes in IL-3- primed basophils, but their efficacy was lower than that of MCP-1 and MCP-3, which were the most potent stimuli of exocytosis. Pretreatment of the basophils with a CCR3-blocking antibody abrogated the migration induced by eotaxin, RANTES, and by low to optimal concentrations of MCP-4, but decreased only minimally the response to MCP-3. The CCR3-blocking antibody also affected exocytosis: it abrogated histamine and leukotriene release induced by eotaxin, and partially inhibited the response to RANTES and MCP-4. In contrast, the antibody did not affect the responses induced by MCP-1, MCP-3, and macrophage inflammatory protein-1alpha, which may depend on CCR1 and CCR2, two additional receptors detected by Northern blotting with basophil RNA. This study demonstrates that CCR3 is the major receptor for eotaxin, RANTES, and MCP-4 in human basophils, and suggests that basophils and eosinophils, which are the characteristic […] Find the latest version: https://jci.me/119624/pdf High Expression of the Chemokine Receptor CCR3 in Human Blood Basophils Role in Activation by Eotaxin, MCP-4, and Other Chemokines Mariagrazia Uguccioni,* Charles R. Mackay,‡ Brigitte Ochensberger,§ Pius Loetscher,ʈ Silvia Rhis,§ Gregory J. LaRosa,‡ Patricia Rao,‡ Paul D. Ponath,‡ Marco Baggiolini,* and Clemens A. Dahinden§ *Theodor Kocher Institute, University of Bern, CH-3000 Bern 9, Switzerland; ‡LeukoSite, Inc., Cambridge, Massachusetts 02142; and §Institute of Immunology and Allergology, ʈDivision of Rheumatology, University Hospital, CH-3010 Bern, Switzerland Abstract generally activate monocytes, lymphocytes, eosinophils, and basophils (2). All chemokines act via seven transmembrane Eosinophil leukocytes express high numbers of the chemo- domain, G protein–coupled receptors (3), and five of them, kine receptor CCR3 which binds eotaxin, monocyte chemo- CCR1–CCR5, are known to mediate responses to CC chemo- tactic protein (MCP)-4, and some other CC chemokines. In kines. The best-characterized ligands are regulated upon acti- this paper we show that CCR3 is also highly expressed on vation normal T cells expressed and secreted (RANTES),1 human blood basophils, as indicated by Northern blotting macrophage inflammatory protein (MIP)-1␣, and monocyte and flow cytometry, and mediates mainly chemotaxis. Eo- chemotactic protein (MCP)-3 for CCR1 (4–7), MCP-1 and taxin and MCP-4 elicited basophil migration in vitro with other MCPs for CCR2 (6, 8, 9), eotaxin, RANTES, and MCP-3 similar efficacy as regulated upon activation normal T cells for CCR3 (10–12), MIP-1␣ and RANTES for CCR4 (13), and expressed and secreted (RANTES) and MCP-3. They also in- MIP-1␣, MIP-1␤, and RANTES for CCR5 (14–16). The ex- duced the release of histamine and leukotrienes in IL-3–primed pression of CC chemokine receptors differs depending on the basophils, but their efficacy was lower than that of MCP-1 type of leukocyte, and influences responsiveness. It is the basis and MCP-3, which were the most potent stimuli of exocyto- for the selectivity observed in the migration of circulating leu- sis. Pretreatment of the basophils with a CCR3-blocking an- kocytes into inflamed tissues in response to chemokines (3). tibody abrogated the migration induced by eotaxin, RANTES, Since eosinophils and basophils are major effector cells in and by low to optimal concentrations of MCP-4, but de- allergic inflammation (17), we have studied two recently char- creased only minimally the response to MCP-3. The CCR3- acterized, powerful eosinophil attractants, eotaxin and MCP-4, blocking antibody also affected exocytosis: it abrogated his- as potential agonists for basophils. Eotaxin has been reported tamine and leukotriene release induced by eotaxin, and to be selective for eosinophils (18) and to act via CCR3 (19). partially inhibited the response to RANTES and MCP-4. In MCP-4 has similar properties, but also acts on monocytes and contrast, the antibody did not affect the responses induced lymphocytes, like other MCPs and RANTES (17, 20–26). In by MCP-1, MCP-3, and macrophage inflammatory protein- this paper, we show that eotaxin and MCP-4 are powerful 1␣, which may depend on CCR1 and CCR2, two additional stimuli for basophils and induce chemotaxis and the release of receptors detected by Northern blotting with basophil RNA. histamine and peptido-leukotrienes. These activities are medi- This study demonstrates that CCR3 is the major receptor ated mainly via CCR3, which is highly expressed both in eosin- for eotaxin, RANTES, and MCP-4 in human basophils, and ophils and basophils. suggests that basophils and eosinophils, which are the char- acteristic effector cells of allergic inflammation, depend Methods largely on CCR3 for migration towards different chemo- kines into inflamed tissues. (J. Clin. Invest. 1997. 100:1137– Chemokines. All chemokines were prepared by automated solid- 1143.) Key words: allergy • inflammation • chemotaxis phase chemical synthesis on a peptide synthesizer (430A; Applied Biosystems, Inc., Foster City, CA) using the tertiary butyloxycarbonyl Introduction and benzyl protection strategy (27). Recombinant human IL-3 was kindly provided by Sandoz, Ltd. (Basel, Switzerland). Chemokines are divided into two main subfamilies according Monoclonal antibodies. The mAb of IgG2a isotype 7B11, which blocks CCR3, was generated as previously described (19). An mAb to the position of the first two cysteines which are either sepa- against the ␣ chain of the high-affinity IgE-receptor (anti-Fc⑀RI) was rated by one amino acid or adjacent (CXC and CC chemo- generously provided by Dr. Hakimi and Dr. Chizzonite (Hoffman-La kines) (1). CXC chemokines attract mainly neutrophils and Roche, Nutley, NJ) (28). FITC-labeled anti-CD9 was purchased from lymphocytes, whereas CC chemokines are more versatile and Serotec Ltd. (Kidlington, Oxford, United Kingdom). Cells. Basophils from venous blood of healthy volunteers (29) were enriched (10–45%) by fractionation in a discontinuous Percoll Address correspondence to Dr. Clemens A. Dahinden, Institute of gradient, and further purified by negative selection with magnetic Immunology and Allergology, University Hospital, Inselspital, CH- beads coated with mAbs against CD3, CD4, CD8, CD14, CD16, and 3010 Bern, Switzerland. Phone: 41-31-632-8244; FAX: 41-31-381- CD19 (30). The final cell suspension consisted of 70–80% basophils 5735; E-mail: [email protected] and 20–30% lymphocytes. Basophils used for RNA extraction were Received for publication 13 March 1997 and accepted in revised purified to near homogeneity by an additional positive selection step form 20 May 1997. using FITC-labeled anti-Fc⑀RI followed by magnetic beads coated J. Clin. Invest. © The American Society for Clinical Investigation, Inc. 1. Abbreviations used in this paper: LTC4, leukotriene C4; MCP, 0021-9738/97/09/1137/07 $2.00 monocyte chemotactic protein; MIP, macrophage inflammatory pro- Volume 100, Number 5, September 1997, 1137–1143 tein; RANTES, regulated upon activation normal T cells expressed http://www.jci.org and secreted. Basophil Activation via CCR3 1137 with anti-FITC. Eosinophils (Ͼ 98% pure) and IL-2–expanded T binding studies, the CCR3 transfectants were treated overnight with 2 lymphocytes were obtained as described previously (25, 31). mM sodium butyrate before harvesting by centrifugation. The cells (5 ϫ Flow cytometry. Mixtures of basophils and mononuclear cells 105) were incubated at room temperature for 90 min with 0.1 nM and of neutrophils and eosinophils were obtained by Percoll gradient 125I-labeled eotaxin or MCP-1 in 100 ␮l binding buffer (50 mM centrifugation without negative selection. The cells suspended in PBS Hepes, pH 7.2, 1 mM CaCl2, 5 mM MgCl2, 0.5% BSA, and 0.02% so- supplemented with 10% FCS and 1 mM EDTA were incubated with dium azide), in the presence of increasing concentrations of unla- anti-CCR3 or isotype-matched control mAb for 30 min on ice and beled chemokines. Bound and free tracer were separated by filtration then treated with PE-conjugated goat anti–mouse Fab (Southern using 96-well GF/B Unifilter plates (Packard, Meriden, CT) pre- Biotechnology Associates, Inc., Birmingham, AL). Two-color stain- soaked in 0.3% polyethylenimine. The filters were washed at 4ЊC ing was performed with FITC-labeled anti-Fc⑀RI for basophils, and with 300 ␮l binding buffer supplemented with 0.5 M NaCl to reduce with FITC-labeled anti-CD9 for eosinophils. After fixation, the cells nonspecific binding. All assays were done in duplicate. IC50 values were analyzed by flow cytometry (FACScan®, Becton Dickinson, (concentrations at which binding of the iodinated chemokine was in- Mountain View, CA). For estimation of anti-CCR3 binding sites, 100 hibited by 50%) were calculated by a three-parameter logistic curve fit ␮l heparinized blood diluted with 100 ␮l PBS containing 0.1% azide using KaleidaGraph software (Synergy Software, Inc., Reading, PA). was incubated at room temperature with 400 ng FITC-labeled anti- CCR3 and 500 ng biotin-coupled anti–human IgE (PharMingen, San Diego, CA). After washing, the cells were stained by addition of 5 ␮l Results Streptavidin-Quantum red (Sigma Chemical Co., St. Louis, MO). Histamine and leukotriene release. In former studies, we have Erythrocytes were lysed, and the leukocytes analyzed by flow cytom- etry.
Load more

Recommended publications
  • HIV-1 Tat Protein Mimicry of Chemokines
    Proc. Natl. Acad. Sci. USA Vol. 95, pp. 13153–13158, October 1998 Immunology HIV-1 Tat protein mimicry of chemokines ADRIANA ALBINI*, SILVANO FERRINI*, ROBERTO BENELLI*, SABRINA SFORZINI*, DANIELA GIUNCIUGLIO*, MARIA GRAZIA ALUIGI*, AMANDA E. I. PROUDFOOT†,SAMI ALOUANI†,TIMOTHY N. C. WELLS†, GIULIANO MARIANI‡,RONALD L. RABIN§,JOSHUA M. FARBER§, AND DOUGLAS M. NOONAN*¶ *Centro di Biotecnologie Avanzate, Istituto Nazionale per la Ricerca sul Cancro, Largo Rosanna Benzi, 10, 16132 Genoa, Italy; †Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development, 14 chemin des Aulx, 1228 Plan-les Ouates, Geneva, Switzerland; ‡Dipartimento di Medicina Interna, Medicina Nucleare, University of Genova, Viale Benedetto XV, 6, 16132 Genoa, Italy; and §National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10, Room 11N228 MSC 1888, Bethesda, MD 20892 Edited by Anthony S. Fauci, National Institute of Allergy and Infectious Diseases, Bethesda, MD, and approved August 25, 1998 (received for review June 24, 1998) ABSTRACT The HIV-1 Tat protein is a potent chemoat- ceptors for some dual tropic HIV-1 strains (10, 11). A CCR2 tractant for monocytes. We observed that Tat shows conserved polymorphism has been found to correlate with delayed amino acids corresponding to critical sequences of the che- progression to AIDS (12, 13). mokines, a family of molecules known for their potent ability We report here that the HIV-1 Tat protein and the peptide to attract monocytes. Synthetic Tat and a peptide (CysL24–51) encompassing the cysteine-rich and core regions induce per- encompassing the ‘‘chemokine-like’’ region of Tat induced a tussis toxin sensitive Ca21 fluxes in monocytes.
    [Show full text]
  • Structural Basis of the Activation of the CC Chemokine Receptor 5 by a Chemokine Agonist
    bioRxiv preprint doi: https://doi.org/10.1101/2020.11.27.401117; this version posted November 27, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Title: Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist One-sentence summary: The structure of CCR5 in complex with the chemokine agonist [6P4]CCL5 and the heterotrimeric Gi protein reveals its activation mechanism Authors: Polina Isaikina1, Ching-Ju Tsai2, Nikolaus Dietz1, Filip Pamula2,3, Anne Grahl1, Kenneth N. Goldie4, Ramon Guixà-González2, Gebhard F.X. Schertler2,3,*, Oliver Hartley5,*, 4 1,* 2,* 1,* Henning Stahlberg , Timm Maier , Xavier Deupi , and Stephan Grzesiek Affiliations: 1 Focal Area Structural Biology and Biophysics, Biozentrum, University of Basel, CH-4056 Basel, Switzerland 2 Paul Scherrer Institute, CH-5232 Villigen PSI, Switzerland 3 Department of Biology, ETH Zurich, CH-8093 Zurich, Switzerland 4 Center for Cellular Imaging and NanoAnalytics, Biozentrum, University of Basel, CH-4058 Basel, Switzerland 5 Department of Pathology and Immunology, Faculty of Medicine, University of Geneva *Address correspondence to: Stephan Grzesiek Focal Area Structural Biology and Biophysics, Biozentrum University of Basel, CH-4056 Basel, Switzerland Phone: ++41 61 267 2100 FAX: ++41 61 267 2109 Email: [email protected] Xavier Deupi Email: [email protected] Timm Maier Email: [email protected] Oliver Hartley Email: [email protected] Gebhard F.X. Schertler Email: [email protected] Keywords: G protein coupled receptor (GPCR); CCR5; chemokines; CCL5/RANTES; CCR5- gp120 interaction; maraviroc; HIV entry; AIDS; membrane protein structure; cryo-EM; GPCR activation.
    [Show full text]
  • Temporal Expression and Cellular Origin of CC Chemokine Receptors
    Journal of Neuroinflammation BioMed Central Research Open Access Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE Sana Eltayeb1, Anna-Lena Berg*2, Hans Lassmann3, Erik Wallström1, Maria Nilsson4, Tomas Olsson1, Anders Ericsson-Dahlstrand4 and Dan Sunnemark4 Address: 1Department of Clinical Neuroscience, Center for Molecular Medicine, Neuroimmunology Unit, Karolinska Institute, S-171 76 Stockholm, Sweden, 2Department of Pathology, Safety Assessment, AstraZeneca R&D Södertälje, S-15185 Södertälje, Sweden, 3Brain Research Institute, University of Vienna, Vienna, Austria and 4Department of Disease Biology, Local Discovery Research Area CNS and Pain Control, AstraZeneca R&D Södertälje, S-151 85 Södertälje, Sweden Email: Sana Eltayeb - [email protected]; Anna-Lena Berg* - [email protected]; Hans Lassmann - [email protected]; Erik Wallström - [email protected]; Maria Nilsson - [email protected]; Tomas Olsson - [email protected]; Anders Ericsson-Dahlstrand - [email protected]; Dan Sunnemark - [email protected] * Corresponding author Published: 7 May 2007 Received: 5 February 2007 Accepted: 7 May 2007 Journal of Neuroinflammation 2007, 4:14 doi:10.1186/1742-2094-4-14 This article is available from: http://www.jneuroinflammation.com/content/4/1/14 © 2007 Eltayeb et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: The CC chemokine receptors CCR1, CCR2 and CCR5 are critical for the recruitment of mononuclear phagocytes to the central nervous system (CNS) in multiple sclerosis (MS) and other neuroinflammatory diseases.
    [Show full text]
  • Cytokine Modulators As Novel Therapies for Airway Disease
    Copyright #ERS Journals Ltd 2001 Eur Respir J 2001; 18: Suppl. 34, 67s–77s European Respiratory Journal DOI: 10.1183/09031936.01.00229901 ISSN 0904-1850 Printed in UK – all rights reserved ISBN 1-904097-20-0 Cytokine modulators as novel therapies for airway disease P.J. Barnes Cytokine modulators as novel therapies for airway disease. P.J. Barnes. #ERS Correspondence: P.J. Barnes Journals Ltd 2001. Dept of Thoracic Medicine ABSTRACT: Cytokines play a critical role in orchestrating and perpetuating National Heart & Lung Institute inflammation in asthma and chronic obstructive pulmonary disease (COPD), and Imperial College Dovehouse Street several specific cytokine and chemokine inhibitors are now in development for the future London SW3 6LY therapy of these diseases. UK Anti-interleukin (IL)-5 is very effective at reducing peripheral blood and airway Fax: 0207 3515675 eosinophil numbers, but does not appear to be effective against symptomatic asthma. Inhibition of IL-4 with soluble IL-4 receptors has shown promising early results in Keywords: Chemokine receptor asthma. Inhibitory cytokines, such as IL-10, interferons and IL-12 are less promising, cytokine as systemic delivery causes side-effects. Inhibition of tumour necrosis factor-a may be interleukin-4 useful in severe asthma and for treating severe COPD with systemic features. interleukin-5 interleukin-9 Many chemokines are involved in the inflammatory response of asthma and COPD interleukin-10 and several low-molecular-weight inhibitors of chemokine receptors are in development. CCR3 antagonists (which block eosinophil chemotaxis) and CXCR2 antagonists (which Received: March 26 2001 block neutrophil and monocyte chemotaxis) are in clinical development for the Accepted April 25 2001 treatment of asthma and COPD respectively.
    [Show full text]
  • Part One Fundamentals of Chemokines and Chemokine Receptors
    Part One Fundamentals of Chemokines and Chemokine Receptors Chemokine Receptors as Drug Targets. Edited by Martine J. Smit, Sergio A. Lira, and Rob Leurs Copyright Ó 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim ISBN: 978-3-527-32118-6 j3 1 Structural Aspects of Chemokines and their Interactions with Receptors and Glycosaminoglycans Amanda E. I. Proudfoot, India Severin, Damon Hamel, and Tracy M. Handel 1.1 Introduction Chemokines are a large subfamily of cytokines (50 in humans) that can be distinguished from other cytokines due to several features. They share a common biological activity, which is the control of the directional migration of leukocytes, hence their name, chemoattractant cytokines. They are all small proteins (approx. 8 kDa) that are highly basic, with two exceptions (MIP-1a, MIP-1b). Also, they have a highly conserved monomeric fold, constrained by 1–3 disulfides which are formed from a conserved pattern of cysteine residues (the majority of chemokines have four cysteines). The pattern of cysteine residues is used as the basis of their division into subclasses and for their nomenclature. The first class, referred to as CXC or a-chemokines, have a single residue between the first N-terminal Cys residues, whereas in the CC class, or b-chemokines, these two Cys residues are adjacent. While most chemokines have two disulfides, the CC subclass also has three members that contain three. Subsequent to the CC and CXC families, two fi additional subclasses were identi ed, the CX3C subclass [1, 2], which has three amino acids separating the N-terminal Cys pair, and the C subclass, which has a single disulfide.
    [Show full text]
  • CCR3, CCR5, Interleukin 4, and Interferon-Γ Expression on Synovial
    CCR3, CCR5, Interleukin 4, and Interferon-γ Expression on Synovial and Peripheral T Cells and Monocytes in Patients with Rheumatoid Arthritis RIIKKA NISSINEN, MARJATTA LEIRISALO-REPO, MINNA TIITTANEN, HEIKKI JULKUNEN, HANNA HIRVONEN, TIMO PALOSUO, and OUTI VAARALA ABSTRACT. Objective. To characterize cytokine and chemokine receptor profiles of T cells and monocytes in inflamed synovium and peripheral blood (PB) in patients with rheumatoid arthritis (RA) and other arthritides. Methods. We studied PB and synovial fluid (SF) samples taken from 20 patients with RA and 9 patients with other arthritides. PB cells from 8 healthy adults were used as controls. CCR3, CCR5, and intracellular interferon-γ (IFN-γ) and interleukin 4 (IL-4) expression in CD8+ and CD8– T cell populations and in CD14+ cells were determined with flow cytometry. Results. Expression of CCR5 and CCR3 by CD8–, CD8+ T cells and CD14+ monocytes was increased in SF compared to PB cells in patients with RA and other arthritides. The number of CD8+ T cells spontaneously expressing IL-4 and IFN-γ was higher in SF than in PB in RA patients. Spontaneous CCR5 expression was associated with intracellular IFN-γ expression in CD8+ T cells derived from SF in RA. In CD8– T cells the ratio of CCR5+/CCR3+ cells was increased in patients with RA compared to patients with other arthritides. The number of PB CD8– T cells expressing IFN-γ after mitogen stimulation was higher in controls than in patients. In PB monocytes the ratio of CCR5+/CCR3+ cells was increased in patients with RA compared to patients with other arthri- tides and controls.
    [Show full text]
  • Role of Chemokines in Hepatocellular Carcinoma (Review)
    ONCOLOGY REPORTS 45: 809-823, 2021 Role of chemokines in hepatocellular carcinoma (Review) DONGDONG XUE1*, YA ZHENG2*, JUNYE WEN1, JINGZHAO HAN1, HONGFANG TUO1, YIFAN LIU1 and YANHUI PENG1 1Department of Hepatobiliary Surgery, Hebei General Hospital, Shijiazhuang, Hebei 050051; 2Medical Center Laboratory, Tongji Hospital Affiliated to Tongji University School of Medicine, Shanghai 200065, P.R. China Received September 5, 2020; Accepted December 4, 2020 DOI: 10.3892/or.2020.7906 Abstract. Hepatocellular carcinoma (HCC) is a prevalent 1. Introduction malignant tumor worldwide, with an unsatisfactory prognosis, although treatments are improving. One of the main challenges Hepatocellular carcinoma (HCC) is the sixth most common for the treatment of HCC is the prevention or management type of cancer worldwide and the third leading cause of of recurrence and metastasis of HCC. It has been found that cancer-associated death (1). Most patients cannot undergo chemokines and their receptors serve a pivotal role in HCC radical surgery due to the presence of intrahepatic or distant progression. In the present review, the literature on the multi- organ metastases, and at present, the primary treatment methods factorial roles of exosomes in HCC from PubMed, Cochrane for HCC include surgery, local ablation therapy and radiation library and Embase were obtained, with a specific focus on intervention (2). These methods allow for effective treatment the functions and mechanisms of chemokines in HCC. To and management of patients with HCC during the early stages, date, >50 chemokines have been found, which can be divided with 5-year survival rates as high as 70% (3). Despite the into four families: CXC, CX3C, CC and XC, according to the continuous development of traditional treatment methods, the different positions of the conserved N-terminal cysteine resi- issue of recurrence and metastasis of HCC, causing adverse dues.
    [Show full text]
  • Plasma Macrophage-Derived Chemokine (CCL22) and Its
    Egypt J Pediatr Allergy Immunol 2005; 3(1): 20-31. Original article Plasma macrophage-derived chemokine (CCL22) and its receptor CCR4 on peripheral blood T lymphocytes of asthmatic children Background: The macrophage-derived chemokine (MDC/CCL22) acts on Mohamed H. Ezzat, CC chemokine receptor-4 (CCR4) to direct trafficking and recruitment of T Karim Y. Shaheen*. helper-2 (TH2) cells into sites of allergic inflammation. It was previously found overexpressed in lesional samples from adult asthmatics. Objective: This study is aimed to investigate the participation of CCR4/MDC axis in the development of TH2-dominated allergen-induced From the Departments childhood asthma in relation to disease activity, attack severity, and of Pediatrics and response to therapy, and to outline its value in differentiating atopic asthma Clinical Pathology*, from infection-associated airway reactivity. Faculty of Medicine, Methods: Proportion of CCR4-expressing peripheral blood T lymphocytes Ain Shams University, + (CCR4 PBTL%) were purified and quantitated by negative selection from Cairo, Egypt. peripheral blood mononuclear cells by flow cytometry, and the concentration of MDC in plasma was measured by ELISA in 32 children with atopic asthma (during exacerbation and remission), as well as in 12 children with acute lower respiratory tract infections (ALRTI), and 20 healthy children serving as controls. Results: The mean plasma MDC level (925±471.5 pg/ml) and CCR4+PBTL% (55.3±23.6%) were significantly higher in asthmatic children during acute attacks in comparison to children with ALRTI (109±27.3 pg/ml and 27.6±7.5%) and healthy controls (99.6±25.6 pg/ml and 24.2±4.1%).
    [Show full text]
  • Cytokine-Directed Therapies in Asthma
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Allergology International (2003) 52: 53–63 Review Article Cytokine-directed therapies in asthma Peter J Barnes National Heart and Lung Institute, Imperial College, London, UK ABSTRACT Multiple cytokines and chemokines have been impli- cated in the pathophysiology of asthma.1 There is now Multiple cytokines play a critical role in orchestrating an intensive search for more specific therapies in and perpetuating inflammation in asthma and several asthma. Inhibitors of cytokines and chemokines figure specific cytokine and chemokine inhibitors are now in prominently in these novel therapeutic approaches2 development as future therapy. Anti-interleukin (IL)-5 (Table 1). antibodies markedly reduce peripheral blood and airway eosinophils, but do not appear to be effective in symptomatic asthma. Inhibition of IL-4, despite prom- STRATEGIES FOR INHIBITING CYTOKINES ising early results in asthma, has been discontinued There are several possible approaches to inhibiting and blocking IL-13 may be more effective. Inhibitory specific cytokines. These range from drugs that inhibit cytokines, such as IL-10, interferons and IL-12 are less cytokine synthesis (glucocorticoids, cyclosporine A, promising, because systemic delivery produces side- tacrolimus, rapamycin, mycophenolate, T helper 2 effects. Inhibition of tumor necrosis factor (TNF)-α may (Th2)-selective inhibitors), humanized blocking anti- be useful in severe asthma. Many chemokines are bodies to cytokines or their receptors, soluble receptors involved in the inflammatory response of asthma and to mop up secreted cytokines, small molecule receptor several small molecule inhibitors of chemokine recep- antagonists or drugs that block the signal transduction tors are in development.
    [Show full text]
  • Colorectal Cancer-Infiltrating T Lymphocytes Display a Distinct
    Löfroos et al. Eur J Med Res (2017) 22:40 DOI 10.1186/s40001-017-0283-8 European Journal of Medical Research RESEARCH Open Access Colorectal cancer‑infltrating T lymphocytes display a distinct chemokine receptor expression profle Ann‑Britt Löfroos1,2†, Mohammad Kadivar2†, Sabina Resic Lindehammer1,2 and Jan Marsal1,2,3* Abstract Background: T lymphocytes exert important homeostatic functions in the healthy intestinal mucosa, whereas in case of colorectal cancer (CRC), infltration of T lymphocytes into the tumor is crucial for an efective anti-tumor immune response. In both situations, the recruitment mechanisms of T lymphocytes into the tissues are essential for the immunological functions deciding the outcome. The recruitment of T lymphocytes is largely dependent on their expression of various chemokine receptors. The aim of this study was to identify potential chemokine receptors involved in the recruitment of T lymphocytes to normal human colonic mucosa and to CRC tissue, respectively, by examining the expression of 16 diferent chemokine receptors on T lymphocytes isolated from these tissues. Methods: Tissues were collected from patients undergoing bowel resection for CRC. Lymphocytes were isolated through enzymatic tissue degradation of CRC tissue and nearby located unafected mucosa, respectively. The expres‑ sion of a broad panel of chemokine receptors on the freshly isolated T lymphocytes was examined by fow cytometry. Results: In the normal colonic mucosa, the frequencies of cells expressing CCR2, CCR4, CXCR3, and CXCR6 dif‑ fered signifcantly between ­CD4+ and ­CD8+ T lymphocytes, suggesting that the molecular mechanisms mediating T lymphocyte recruitment to the gut difer between ­CD4+ and ­CD8+ T lymphocytes.
    [Show full text]
  • Mice Chemokine Receptors CCR2 and CCR5 in Expression and Characterization Of
    Expression and Characterization of the Chemokine Receptors CCR2 and CCR5 in Mice This information is current as Matthias Mack, Josef Cihak, Christopher Simonis, Bruno of September 28, 2021. Luckow, Amanda E. I. Proudfoot, Jir?í Plachý, Hilke Brühl, Michael Frink, Hans-Joachim Anders, Volker Vielhauer, Jochen Pfirstinger, Manfred Stangassinger and Detlef Schlöndorff J Immunol 2001; 166:4697-4704; ; Downloaded from doi: 10.4049/jimmunol.166.7.4697 http://www.jimmunol.org/content/166/7/4697 References This article cites 40 articles, 27 of which you can access for free at: http://www.jimmunol.org/ http://www.jimmunol.org/content/166/7/4697.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on September 28, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2001 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Expression and Characterization of the Chemokine Receptors CCR2 and CCR5 in Mice1 Matthias Mack,2* Josef Cihak,† Christopher Simonis,* Bruno Luckow,* Amanda E. I.
    [Show full text]
  • Mapping the Intracellular Molecular Mechanisms of Chemokine Signalling Within Cancer
    Mapping the intracellular molecular mechanisms of chemokine signalling within cancer Gerald Roman Sion Keil A thesis presented for the degree of Doctor of Philosophy at the University of East Anglia, School of Pharmacy March 2019 "This copy of the thesis has been supplied on condition that anyone who consults it is understood to recognise that its copyright rests with the author and that use of any information derived therefrom must be in accordance with current UK Copyright Law. In addition, any quotation or extract must include full attribution.” Abstract Chemokines are extracellular signalling molecules which function as chemoattractants for leukocytes by directing their migration towards sites of inflammation as part of the immune response. On epithelial cells chemokine receptor expression is normally low or absent. However during cancer progression, chemokine receptors can become overexpressed on cancer cells, whilst chemokines are frequently present at sites of metastasis. Consequently aberrant chemokine signalling is associated with both metastasis and a poor prognosis in cancer patients. The chemokine signalling network is therefore consider a potential therapeutic target for cancer treatment. The aim of the research undertaken in this thesis was to identify novel therapeutic targets involved in chemokine downstream signalling in cancer cells. To investigate the chemokine downstream signalling pathway, a number of different chemokines and small molecules were used with their effects on cellular intracellular calcium signalling and migration of different leukemic and carcinoma cells assessed. The findings from the screen identified a role for CCL2 and CCL3 signalling in the migration of PC-3 and MCF-7 cells respectively. In MCF-7 cells, CXCL12 intracellular calcium signalling was shown to be dependent on Gαi, Syk/Src, c- Raf, DOCK1/2/5 and Arp2/3.
    [Show full text]